NEW

Bon Secours Health System in Ireland chooses Hyland Healthcare to manage clinical content enterprise-wide

Bon Secours Health System, the largest private health care provider in Ireland, has selected OnBase, Hyland's enterprise information platform, to digitize and manage clinical documents. The platform will optimize workflows and performance across the enterprise,...

RSNA 2020 Registration Tops 14,000 Six Weeks Ahead of Meeting

With strong advance registration numbers, the Radiological Society of North America (RSNA) 106th Scientific Assembly and Annual Meeting (RSNA 2020) is shaping up to be a success. Six weeks ahead of the meeting, 14,125 people from countries around the world are already...

Varian Stockholders Approve Combination with Siemens Healthineers

Varian has announced that its stockholders have voted to approve the previously announced pending combination with Siemens Healthineers AG at a special meeting. Varian stockholders voted overwhelmingly in favor of the transaction. "The overwhelming support our...

See-Mode Technologies Receives FDA Clearance for AI Software

See-Mode Technologies, a MedTech startup based in Singapore and Australia that seeks to empower clinicians to better predict stroke, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its debut product, Augmented...

GE Healthcare Serena Bright

Typically lesions identified with contrast-enhanced mammography are sent to MRI for biopsy, but now with Serena Bright, the industry-first contrasted enhanced biopsy-guided solution, breast biopsy procedures can be performed with the same mammography equipment, with the same staff and in the same room as the screening or diagnostic mammogram. Key to this technology’s application is GE Healthcare’s SenoBright HD Contrast Enhanced Spectral Mammography, a diagnostic imaging tool that delivers high sensitivity for more accurate breast cancer diagnosis.[1] By highlighting areas of unusual blood flow to help localize lesions that need biopsy, Serena Bright can help improve radiologists’ diagnostic confidence.[2] Serena Bright will be commercially available in the United States in October 2020.

1. Contrast-Enhanced Mammography: A Systematic Guide to Interpretation and Reporting. AJR https://www.ajronline.org/doi/full/10.2214/AJR.17.19265
2. 510(k) Premarket Notification Submission: https://www.accessdata.fda.gov/cdrh_docs/pdf19/K193334.pdf

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *